PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage
Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on January 9, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: January 09, 2026 Cyfuse Biomedical K.K. [4892.T] TOKYO — Cyfuse Biomedical K.K. (4892), a leading biomedical company, announced on Monday that it has completed the payment of the total issuance amount of 199,992,800 yen for its new share issue to third parties, which was resolved upon by the board of directors on December 24, 2025. The new shares were issued as part of a capital tie-up agreement with Kuraray Co., Ltd., and detailed information regarding this trans